drugset / Trial / NCT03925740
MI and PreviDent Varnish on Non Cavitated Interproximal Lesions.
RandomizedParallel-groupDouble-blindPrevention
Summary
Fluoride products are proven to be cost effective in preventing dental caries. Newer Fluoride products have been released in the market with different components that may have an impact on the clinical and radiographic outcome regarding incipient caries management. The objective of the study is to compare the effectiveness of PreviDent and MI varnish to (1.23%) Acidulated phosphopeptide Fluoride (APF) on remineralisation of non-cavitated proximal incipient lesions.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-05-29
- Completion
- 2020-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 1.23% APF | Unknown | — | — |
| Subject | MI Varnish | Unknown | — | — |
| Subject | PreviDent Varnish | Unknown | — | — |
Indications
No indication recorded.